美国泌尿生殖系统癌症发病率和死亡率的差异与趋势
该研究利用SEER、美国癌症统计和国家卫生统计中心数据,按性别、种族/族裔和县分析四种主要泌尿生殖系统癌症的发病与死亡趋势。发现膀胱癌和肾癌男性发病率与死亡率是女性的两到四倍,肾癌、睾丸癌及晚期前列腺癌发病率在几乎所有种族/族裔人群中上升,睾丸癌死亡率在西班牙裔中上升。
要点
- 膀胱癌和肾癌的发病率和死亡率男性为女性的两到四倍。
- 肾癌、睾丸癌及晚期前列腺癌发病率在几乎所有种族/族裔人群中上升。
- 美国印第安人/阿拉斯加原住民膀胱癌发病率上升,西班牙裔睾丸癌死亡率上升。
核心结论
- 四种主要泌尿生殖系统癌症均存在持续的社会人口学差异以及不利的发病率或死亡率趋势。
- 未来研究应阐明这些模式的原因。
研究设计与样本
- 发病数据来自美国国家癌症研究所22个注册中心的监测、流行病学和最终结果(SEER)数据库及美国癌症统计数据库(疾病控制与预防中心),死亡数据来自国家卫生统计中心。
- 采用横断面和时间趋势分析,按性别、种族/族裔和县分层计算年龄调整发病率和死亡率。
- 使用SEER*Stat软件计算年龄调整率,采用Joinpoint回归分析时间趋势,双侧显著性水平为p < 0.05。
主要发现
- 膀胱癌和肾癌的发病率和死亡率男性为女性的两到四倍。
- 在非西班牙裔白人个体中,膀胱癌发病率最高在东北部,肾癌发病率最高在阿巴拉契亚地区,前列腺癌死亡率最高在西部。
- 肾癌、睾丸癌及晚期前列腺癌的发病率在几乎所有种族/族裔人群中上升,膀胱癌发病率在美国印第安人/阿拉斯加原住民人群中上升。
- 睾丸癌死亡率在西班牙裔人群中上升;前列腺癌死亡率在自20世纪90年代初持续下降后,在 white 和亚裔美国人/太平洋岛民男性中趋于稳定。
局限性
- 研究局限性包括医疗记录和死亡证明上种族/族裔的错误分类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies have reported on incidence and mortality patterns for individual genitourinary cancers in the USA. However, these studies addressed individual cancer types rather than genitourinary cancers overall. OBJECTIVE: To comprehensively examine disparities and trends in the incidence and mortality for the four major genitourinary cancers (bladder, kidney, prostate, and testis) in the USA. DESIGN, SETTING, AND PARTICIPANTS: We obtained incidence data from the National Cancer Institute 22-registry Surveillance, Epidemiology and End Results (SEER) database and the US Cancer Statistics database (Centers for Disease Control and Prevention) and mortality data from the National Center for Health Statistics to examine cross-sectional and temporal trends in incidence and death rates stratified by sex, race/ethnicity, and county. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Age-adjusted incidence and death rates were calculated using SEER*Stat software. Temporal trends were analyzed using Joinpoint regression for a two-sided significance level of p < 0.05. RESULTS AND LIMITATIONS: Incidence and mortality rates for bladder and kidney cancers were two to four times higher for men than for women. Among non-Hispanic White individuals, the highest incidence rates were found in the Northeast for bladder cancer and in Appalachia for kidney cancer, whereas the highest death rates for prostate cancer were found in the West. Incidence rates increased for cancers of the kidney and testis and for advanced-stage prostate cancer in almost all racial/ethnic populations and for bladder cancer in the American Indian/Alaska Native population. Death rates increased for testicular cancer in the Hispanic population and stabilized for prostate cancer among White and Asian American/Pacific Islander men after a steady decline since the early 1990s. Study limitations include misclassification of race/ethnicity on medical records and death certificates. CONCLUSIONS: We found persistent sociodemographic disparities and unfavorable trends in incidence or mortality for all four major genitourinary cancers. Future studies should elucidate the reasons for these patterns. PATIENT SUMMARY: In the USA, rates of cancer cases are increasing for kidney, testis, and advanced-stage prostate cancers in the overall population, and for bladder cancer in the American Indian/Alaska Native population. Differences in the rates by sex and race/ethnicity remain.
引用
- Schafer EJ, Jemal A, Wiese D, et al. Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USA. Eur Urol. 2022. PMID: 36566154. doi:10.1016/j.eururo.2022.11.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。